TUBE project (2019-2023) investigated transport-derived ultrafine particles and their effects on brain health, Alzheimer's disease, and neuroinflammation.
SUN YAT-SEN UNIVERSITY
Major Chinese university contributing neurotoxicology, rapid diagnostics, and environmental health expertise to European research consortia.
Their core work
Sun Yat-sen University is a major Chinese research university based in Guangzhou with selective but targeted involvement in European research. Their H2020 contributions center on health-related research — specifically the neurotoxic effects of transport-derived air pollution on the brain, and rapid diagnostic tools for infectious diseases like COVID-19. They also bring expertise in agricultural waste valorization and smart transport technologies, reflecting a broad life sciences and environmental research base.
What they specialise in
CORONADX project (2020-2023) developed three rapid COVID-19 diagnostic tests with associated epidemiological and socio-economic analysis.
NoAW project (2016-2021) explored turning agricultural waste into ecological and economic assets.
TESTBED project (2017-2019) tested and evaluated advanced ICT for enabling smart transport systems.
How they've shifted over time
Sun Yat-sen University's early H2020 involvement (2016-2017) covered broad applied topics — agricultural waste management and smart transport ICT — without a strong thematic signature. From 2019 onward, they shifted decisively toward health and biomedical research, focusing on the neurotoxic effects of nanoparticles from traffic and rapid point-of-care diagnostics. This recent concentration on environmental health impacts and diagnostic technology represents a clear narrowing toward medically relevant, translational research.
Moving toward health-oriented research at the intersection of environmental exposure science and rapid diagnostics — expect future interest in air pollution health impacts and point-of-care medical devices.
How they like to work
Sun Yat-sen University exclusively participates as a partner or third party — they have never coordinated an H2020 project, which is typical for non-EU institutions joining European consortia as international collaborators. With 65 unique partners across 19 countries from just 4 projects, they join large, well-connected consortia rather than small focused teams. This suggests they are brought in for specific expertise contributions rather than driving project direction.
Despite only 4 projects, they have built connections with 65 partners across 19 countries, indicating participation in large multi-national consortia. Their network spans broadly across Europe and beyond, reflecting their role as a valued international collaborator brought into established European research groups.
What sets them apart
As a top-tier Chinese university, Sun Yat-sen brings access to large patient populations, extensive in vitro and in vivo testing capabilities, and a research infrastructure that complements European partners. Their combination of inhalation toxicology expertise with brain health research is relatively rare and positions them well for projects linking environmental exposure to neurological disease. For consortia needing a strong Asian partner with health sciences depth, they are a credible choice with proven H2020 experience.
Highlights from their portfolio
- TUBEDirectly links traffic-generated nanoparticles to brain diseases including Alzheimer's — a high-impact, cross-disciplinary topic bridging transport and health.
- CORONADXTheir only funded project (EUR 205,895), developing rapid COVID-19 diagnostics — demonstrates capability in point-of-care medical device research with clear real-world urgency.